Tran, N. H., Foster, N. R., Mahipal, A., Byrne, T., Hubbard, J., Silva, A., . . . Borad, M. J. (2021). Phase IB Study of Sorafenib and Evofosfamide in Patients with Advanced Hepatocellular and Renal Cell Carcinomas (NCCTG N1153, Alliance). Invest New Drugs.

Tran, Nguyen H., Nathan R. Foster, Amit Mahipal, Thomas Byrne, Joleen Hubbard, Alvin Silva, Kabir Mody, Steven Alberts, and Mitesh J. Borad. "Phase IB Study of Sorafenib and Evofosfamide in Patients With Advanced Hepatocellular and Renal Cell Carcinomas (NCCTG N1153, Alliance)." Invest New Drugs 2021.

Tran, Nguyen H., et al. "Phase IB Study of Sorafenib and Evofosfamide in Patients With Advanced Hepatocellular and Renal Cell Carcinomas (NCCTG N1153, Alliance)." Invest New Drugs 2021.